1. Home
  2. RCEL vs NATH Comparison

RCEL vs NATH Comparison

Compare RCEL & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • NATH
  • Stock Information
  • Founded
  • RCEL 2020
  • NATH 1916
  • Country
  • RCEL United States
  • NATH United States
  • Employees
  • RCEL N/A
  • NATH N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • NATH Restaurants
  • Sector
  • RCEL Health Care
  • NATH Consumer Discretionary
  • Exchange
  • RCEL Nasdaq
  • NATH Nasdaq
  • Market Cap
  • RCEL 342.7M
  • NATH 338.5M
  • IPO Year
  • RCEL N/A
  • NATH N/A
  • Fundamental
  • Price
  • RCEL $11.77
  • NATH $79.39
  • Analyst Decision
  • RCEL Hold
  • NATH
  • Analyst Count
  • RCEL 3
  • NATH 0
  • Target Price
  • RCEL $16.50
  • NATH N/A
  • AVG Volume (30 Days)
  • RCEL 96.7K
  • NATH 14.5K
  • Earning Date
  • RCEL 02-20-2025
  • NATH 01-30-2025
  • Dividend Yield
  • RCEL N/A
  • NATH 2.52%
  • EPS Growth
  • RCEL N/A
  • NATH 11.31
  • EPS
  • RCEL N/A
  • NATH 5.34
  • Revenue
  • RCEL $60,040,000.00
  • NATH $143,757,000.00
  • Revenue This Year
  • RCEL $40.34
  • NATH N/A
  • Revenue Next Year
  • RCEL $52.79
  • NATH N/A
  • P/E Ratio
  • RCEL N/A
  • NATH $14.86
  • Revenue Growth
  • RCEL 32.24
  • NATH 7.04
  • 52 Week Low
  • RCEL $7.51
  • NATH $63.01
  • 52 Week High
  • RCEL $18.93
  • NATH $94.97
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 43.48
  • NATH 38.77
  • Support Level
  • RCEL $11.30
  • NATH $82.49
  • Resistance Level
  • RCEL $12.75
  • NATH $87.57
  • Average True Range (ATR)
  • RCEL 0.74
  • NATH 2.90
  • MACD
  • RCEL -0.24
  • NATH -0.75
  • Stochastic Oscillator
  • RCEL 18.01
  • NATH 0.00

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: